TTP Extends Global Reach
News Apr 04, 2007
Success of mosquito® and Acumen® eX3 leads new distribution agreements for Japan, India and Australia/New Zealand.
After building up a strong base of customers in the USA and Europe over the past three years, TTP LabTech have now appointed distributors for Japan (AsOne Corporation, Osaka), India (Wipro Limited, Biomed Division, Bangalore), and Australia/New Zealand (Millennium Science, Victoria).
Covering LabTech’s nanolitre liquid handler, mosquito®, and their new microplate cytometer, Acumen® eX3, these exclusive agreements have already led to multiple sales in these territories.
Commenting on the new appointments, Jas Sanghera, TTP LabTech’s Commercial Director, said “mosquito and the Acumen eX3 both have enviable reputations and are seen as first choice instruments in a number of application areas. With an established customer base in our traditional markets and high capacity manufacturing capabilities, we felt the time was right to expand globally.
Having been approached by a number of possible distributors we have signed agreements with companies that really fit with the TTP LabTech ethos; they understand the researcher’s needs and have a reputation for excellent customer service and support.”
The ideal drug is one that only affects the exact cells and neurons it is designed to treat, without unwanted side effects. This concept is especially important when treating the delicate and complex human brain. Now, scientists have revealed a mechanism that could lead to this kind of long-sought specificity for treatments of strokes and seizures.READ MORE